Non-Invasive Prenatal Testing for Fetal Aneuploidy (Panorama)
2007537
Ordering Recommendation
Screens for trisomy 13, 18, 21; Turner syndrome; and triploidy. Recommended for women at high risk for a fetal chromosomal aneuploidy. This includes women who 1) are 35 years or older at delivery, 2) have had a previous child with aneuploidy, 3) have a fetus with identified ultrasound anomalies associated with the above aneuploidies, or 4) have screened positive by maternal serum screening testing in the current pregnancy.
Mnemonic
NIPT ANEU
Methodology
Targeted sequencing with SNPs
Performed
Varies
Reported
12-14 days  
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
  
Collect
Whole blood in Cell-Free DNA BCT Tube.  All specimens must be collected using the NIPT ANEU kit (ARUP Supply #50223). Available online through eSupply or contacting ARUP Client Services at (800) 522-2787.
Required Specimen: Maternal specimens must be collected in 2 Cell-Free DNA BCT tubes.
Optional Specimen: Paternal specimens must be collected in buccal brush.  
Specimen Preparation
Transport 20 mL maternal blood in Cell-Free DNA BCT Tube (ARUP Supply #50223) and optional paternal buccal brush. (Min: 16 mL) Available online through eSupply or contacting ARUP Client Services at (800) 522-2787.  A paternal specimen is requested but is not required for testing. The paternal specimen cannot be tested alone and must be provided along with the maternal blood. Do not send the buccal brush separately.  
Storage/Transport Temperature
Room temperature.  
Unacceptable Conditions
  
Remarks
Patient History and Informed Consent for Non-Invasive Prenatal Testing (NIPT) form required. Testing utilizes a single-nucleotide polymorphism (SNP)/ informatics-based approach to detect fetal copy number for the five chromosomes responsible for the majority of live-birth aneuploidies (chromosomes 13, 18, 21, X, Y, and triploidy). This is a screening test to help identify fetuses at risk for Down Syndrome, trisomy 18, trisomy 13 and Turner Syndrome. This test should not be considered diagnostic.  It is recommended that any positive result should be confirmed by amniocentesis or CVS.  
Stability
Ambient: 5 days; Refrigerated: Unacceptable; Frozen: Unacceptable  
Reference Interval
By report  
Interpretive Data
Refer to report.  
Note
 
CPT Code(s)
81507
Components
Component Test Code*Component Chart NameLOINC
2007538EER Non-Invasive Prenatal, Aneuploidy11526-1
2008381Trisomy 2173966-4
2008382Trisomy 1873825-2
2008383Trisomy 1373824-5
2008386Monosomy X73821-1
2008430Fetal Fraction 
2008431Report Fetus Gender8251-1
2008830Triploidy/Vanishing Twin 
2009259Result Summary48767-8
2009260Gestational Age (Weeks)49051-6
2010002Maternal Weight (Pounds)8338-6
2010003Gestational Age (Days)49052-4
2010004Fetus Gender11882-8
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • 45X
  • Ariosa
  • cell-free
  • cellfree
  • cffDNA
  • edward syndrome
  • Harmony
  • MaterniT21
  • Maternity21
  • Natera
  • NIPD
  • Panorama
  • patau syndrome
  • Sequenom
  • T13
  • T18
  • trisomy 21
  • Verifi
  • Verinata

Performed at Natera